Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules
暂无分享,去创建一个
[1] I. Berenblum. Cancer prevention as a realizable goal , 1981, Cancer.
[2] I. Weinstein,et al. Differential excision from DNA of the C-8 and N2 guanosine adducts of N-acetyl-2-aminofluorene by single strand-specific endonucleases. , 1977, Cancer research.
[3] B. Ketterer. INteractions between carcinogens and proteins. , 1980, British medical bulletin.
[4] J. Clemmesen. On the etiology of some human cancers. , 1951, Journal of the National Cancer Institute.
[5] E. Kriek. Persistent binding of a new reaction product of the carcinogen N-hydroxy-N-2-acetylaminofluorene with guanine in rat liver DNA in vivo. , 1972, Cancer research.
[6] J. Radomski,et al. Bladder Cancer Induction by Aromatic Amines: Role of N-Hydroxy Metabolites , 1970, Science.
[7] E. Miller,et al. The Mutagenicity of Chemical Carcinogens: Correlations, Problems, and Interpretations , 1971 .
[8] J. Miller,et al. The metabolic activation of the carcinogen 1'-hydroxysafrole in vivo and in vitro and the electrophilic reactivities of possible ultimate carcinogens. , 1976, Cancer research.
[9] A. Loveless,et al. Possible Relevance of O–6 Alkylation of Deoxyguanosine to the Mutagenicity and Carcinogenicity of Nitrosamines and Nitrosamides , 1969, Nature.
[10] I. Purchase,et al. An evaluation of 6 short-term tests for detecting organic chemical carcinogens. , 1978, British Journal of Cancer.
[11] J. Miller,et al. THE CARCINOGENICITY OF CERTAIN DERIVATIVES OF p-DIMETHYLAMINOAZOBENZENE IN THE RAT , 1948, The Journal of experimental medicine.
[12] H. Druckrey,et al. CHEMICAL STRUCTURE AND CARCINOGENICITY OF ALIPHATIC HYDRAZO, AZO, AND AZOXY COMPOUNDS AND OF TRIAZENES, POTENTIAL IN VIVO ALKYLATING AGENTS * , 1969 .
[13] H. Richardson,et al. Liver tumor inhibition and adrenal histologic responses in rats to which 3'-methyl-4-dimethylaminoazobenzene and 20-methylcholanthrene were simultaneously administered. , 1952, Cancer research.
[14] S. Thorgeirsson,et al. Mutagenic activation of N-hydroxy-2-acetylaminofluorene in the Salmonella test system: the role of deacetylation by liver and kidney fractions from mouse and rat. , 1978, Molecular pharmacology.
[15] R. Boutwell,et al. The function and mechanism of promoters of carcinogenesis. , 1974, CRC critical reviews in toxicology.
[16] C. Heidelberger,et al. The distribution of radioactivity in the mouse following administration of dibenzanthracene labeled in the 9 and 10 positions with carbon 14 , 1948, Cancer.
[17] W. E. Scott,et al. Isolation of the glucuronic acid conjugate of n-hydroxy-4-aminobiphenyl from dog urine and its mutagenic activity. , 1977, Cancer research.
[18] E. Miller. Some current perspectives on chemical carcinogenesis in humans and experimental animals: Presidential Address. , 1978, Cancer research.
[19] E. Kriek,et al. On the mechanism of action of carcinogenic aromatic amines. I. Binding of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene to rat-liver nucleic acids in vivo. , 1969, Chemico-biological interactions.
[20] J. Miller,et al. Substrate-induced synthesis and other properties of benzpyrene hydroxylase in rat liver. , 1957, The Journal of biological chemistry.
[21] J. Miller,et al. Structures of hepatic nucleic acid-bound dyes in rats given the carcinogen N-methyl-4-aminoazobenzene. , 1975, Cancer research.
[22] W. Haenszel,et al. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. , 1968, Journal of the National Cancer Institute.
[23] M. S. Zedeck,et al. Organ-specific effects of the carcinogen methylazoxymethanol related to metabolism by nicotinamide adenine dinucleotide-dependent dehydrogenases. , 1977, Cancer research.
[24] P. Talalay,et al. Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[25] A. Dipple,et al. Studies on the formation of hydrocarbon-deoxyribonucleoside products by the binding of derivatives of 7-methylbenz(a)anthracene to DNA in aqueous solution and in mouse embryo cells in culture. , 1973, Cancer research.
[26] J. Miller,et al. N-hydroxy-2-acetylaminofluorene sulfotransferase: its probable role in carcinogenesis and in protein-(methion-S-yl) binding in rat liver. , 1970, Cancer research.
[27] J. Miller,et al. 3-methylmercapto-N-methyl-4-aminoazobenzene: an alkaline-degradation product of a labile protein-bound dye in the livers of rats fed N,N-dimethyl-4-aminoazobenzene. , 1965, Biochemical and biophysical research communications.
[28] J. Miller,et al. N-Benzoyloxy-N-methyl-4-aminoazobenzene: its carcinogenic activity in the rat and its reactions with proteins and nucleic acids and their constituents in vitro. , 1967, Cancer research.
[29] J. Miller,et al. Hepatic metabolism of N-hydroxy-N-methyl-4-aminoazobenzene and other N-hydroxy arylamines to reactive sulfuric acid esters. , 1976, Cancer research.
[30] D. Jerina,et al. Tumorigenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides in newborn mice: exceptional activity of (+)-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[31] C. King,et al. Enzyme-Catalyzed Reactions of the Carcinogen N-Hydroxy-2-fluorenylacetamide with Nucleic Acid , 1968, Science.
[32] A. Mattocks. Toxicity of Pyrrolizidine Alkaloids , 1968, Nature.
[33] L. Wattenberg. Inhibitors of chemical carcinogenesis. , 1978, Advances in cancer research.
[34] J. Huff,et al. An evaluation of chemicals and industrial processes associated with cancer in humans based on human and animal data: IARC Monographs Volumes 1 to 20. , 1980, Cancer research.
[35] C. Harris,et al. Benzo(a)pyrene diol epoxides as intermediates in nucleic acid binding in vitro and in vivo. , 1976, Science.
[36] B. Ames,et al. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals: discussion. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. Mottram. A developing factor in experimental blastogenesis , 1944 .
[38] P. Grover,et al. Enzyme-catalysed reactions of polycyclic hydrocarbons with deoxyribonucleic acid and protein in vitro. , 1968, The Biochemical journal.
[39] B. Blumberg. Australia antigen and the biology of hepatitis B. , 1977, Science.
[40] P. Rous,et al. CONDITIONAL NEOPLASMS AND SUBTHRESHOLD NEOPLASTIC STATES , 1941, The Journal of experimental medicine.
[41] J. Weisburger,et al. Chemistry, carcinogenicity, and metabolism of 2-fluorenamine and related compounds. , 1958, Advances in cancer research.
[42] H. Gelboin. A microsome-dependent binding of benzo[a]pyrene to DNA. , 1969, Cancer research.
[43] D. Jerina,et al. Benzo[a]pyrene 7,8-dihydrodiol is more carcinogenic than benzo[a]pyrene in newborn mice , 1977, Nature.
[44] J. Miller,et al. The reactivity and carcinogenicity of aflatoxin B1-2,3-dichloride, a model for the putative 2,3-oxide metabolite of aflatoxin B1. , 1975, Cancer research.
[45] C. Heidelberger,et al. Binding of K-region epoxides and other derivatives of benz(a)anthracene and dibenz(a,h)anthracene to DNA, RNA, and proteins of transformable cells. , 1972, Chemico-biological interactions.
[46] S. Sorof,et al. Evidence for a receptor protein of activated carcinogen. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[47] R. C. Garner,et al. The halogenation and attempted epoxidation of 3a,8a-dihydrofuro[2,3-b]benzofuran and aflatoxin B1 , 1979 .
[48] E C Miller,et al. Mechanisms of chemical carcinogenesis: nature of proximate carcinogens and interactions with macromolecules. , 1966, Pharmacological reviews.
[49] J. Miller,et al. Microsomal N-oxidation of the hepatocarcinogen N-methyl-4-aminoazobenzene and the reactivity of N-hydroxy-N-methyl-4-aminoazobenzene. , 1976, Cancer research.
[50] C. Irving,et al. Persistent binding of 2-acetylaminofluorene to rat liver DNA in vivo and consideration of the mechanism of binding of N-hydroxy-2-acetylaminofluorene to rat liver nucleic acids. , 1969, Cancer research.
[51] A. Mattocks. Dihydropyrrolizine derivatives from unsaturated pyrrolizidine alkaloids. , 1969, Journal of the Chemical Society. Perkin transactions 1.
[52] J. Miller,et al. Reactivity of the diacetyl derivative of the carcinogen 4-hydroxyaminoquinoline-1-oxide with DNA, RNA, and other nucleophiles. , 1968, Life sciences.
[53] J. Miller,et al. 1'-Hydroxysafrole, a proximate carcinogenic metabolite of safrole in the rat and mouse. , 1973, Cancer research.
[54] J. Miller,et al. 8-(N-2-fluorenylacetamido)guanosine, an arylamidation reaction product of guanosine and the carcinogen N-acetoxy-N-2-fluorenylacetamide in neutral solution. , 1967, Biochemistry.
[55] F. Crick,et al. Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid , 1953, Nature.
[56] J. Miller,et al. Reactions in vitro of some tissue nucleophiles with the glucuronide of the carcinogen N-hydroxy-2-acetylaminofluorene. , 1968, Molecular pharmacology.
[57] J. Miller,et al. Adducts from the reaction of N-benzoyloxy-N-methyl-4-aminoazobenzene with deoxyguanosine or DNA in vitro and from hepatic DNA of mice treated with N-methyl- or N,N-dimethyl-4-aminoazobenzene. , 1980, Cancer research.
[58] H. Matsumoto,et al. Studies on methylazoxymethanol, the aglycone of cycasin: methylation of nucleic acids in vitro. , 1966, The Biochemical journal.
[59] S. A. Henry. Occupational cutaneous cancer attributable to certain chemicals in industry. , 1946, British medical bulletin.
[60] N. Mantel,et al. Carcinogenicity testing of selected food additives by parenteral administration to infant Swiss mice. , 1970, Toxicology and applied pharmacology.
[61] T. V. Wang,et al. Spontaneous reactions of aflatoxin B1 modified deoxyribonucleic acid in vitro. , 1980, Biochemistry.
[62] C. Heidelberger,et al. An epoxide is an intermediate in the microsomal metabolism of the chemical carcinogen, dibenz(a,h)anthracene. , 1971, Biochemical and biophysical research communications.
[63] J. Miller,et al. In vivo combinations between carcinogens and tissue constituents and their possible role in carcinogenesis. , 1952, Cancer research.
[64] A. Pegg. Studies of the ethylation of rat liver transfer ribonucleic acid after administration of L-ethionine. , 1972, The Biochemical journal.
[65] A. Haddow. Sir Ernest Laurence Kennaway FRS, 1881-1958: Chemical Causation of Cancer Then and Today , 2015, Perspectives in biology and medicine.
[66] EDWARD D. COPS,et al. The Survival of the Fittest , 1872, Nature.
[67] P. Shubik,et al. Survey of Compounds Which Have Been Tested for Carcinogenic Activity , 1941 .
[68] E C Miller,et al. Structures of the DNA adducts formed in mouse liver after administration of the proximate hepatocarcinogen 1'-hydroxyestragole. , 1981, Cancer research.
[69] J. Lefèvre,et al. Comparative orientation of the fluorene residue in native DNA modified by N-acetoxy-N-2-acetylaminofluorene and two 7-halogeno derivatives. , 1976, Biochemistry.
[70] J. Miller,et al. Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis. , 1977, Cancer research.
[71] E. Miller. Studies on the formation of protein-bound derivatives of 3,4-benzpyrene in the epidermal fraction of mouse skin. , 1951, Cancer research.
[72] J. Miller,et al. The metabolic activation of carcinogenic aromatic amines and amides. , 1969, Progress in experimental tumor research.
[73] J. Miller,et al. Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivo. , 1977, Cancer research.
[74] J. Miller,et al. N-hydroxy metabolites of 2-acetylaminophenanthrene and 7-fluoro-2-acetylaminofluorene as proximate carcinogens in the rat. , 1966, Cancer research.
[75] J. Miller,et al. The carcinogenic aminoazo dyes. , 1953, Advances in cancer research.
[76] G. Williams,et al. On the sulfate ester of N-hydroxy-N-2-fluorenylacetamide as a key ultimate hepatocarcinogen in the rat. , 1972, Cancer research.
[77] L. S. Andrews,et al. Studies on the mutagenicity of N-hydroxy-2-acetylaminofluorene in the Ames-Salmonella mutagenesis test system. , 1978, Biochemical pharmacology.
[78] H. Pitot,et al. The stages of initiation and promotion in hepatocarcinogenesis. , 1980, Biochimica et biophysica acta.
[79] I. Berenblum. The modifying influence of dichloro‐ethyl sulphide on the induction of tumours in mice by tar , 1929 .
[80] E. Fiala,et al. Inhibition of the metabolism of the colon carcinogen, azoxymethane, by pyrazole. , 1978, Cancer research.
[81] C. King. Mechanism of reaction, tissue distribution, and inhibition of arylhydroxamic acid acyltransferase. , 1974, Cancer research.
[82] I. Berenblum. The Cocarcinogenic Action of Croton Resin , 1941 .
[83] J. Essigmann,et al. Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[84] J. Miller,et al. The reductive cleavage of 4-dimethylaminoazobenzene by rat liver; the intracellular distribution of the enzyme system and its requirement for triphosphopyridine nucleotide. , 1949, The Journal of biological chemistry.
[85] L. Sachs,et al. Identification of mutagenic metabolites of benzo(a)pyrene in mammalian cells. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[86] Miller Ec,et al. The Carcinogenicity of p-Monomethylaminoazobenzene in Various Diets and the Activity of this Dye Relative to p-Dimethylaminoazobenzene , 1946 .
[87] A. Pegg,et al. Evidence for ethylation of rat liver deoxyribonucleic acid after administration of ethionine. , 1971, The Biochemical journal.
[88] G. Wogan,et al. Structure-activity relationships in toxicity and carcinogenicity of aflatoxins and analogs. , 1971, Cancer research.
[89] H. Bartsch,et al. On the metabolic activation of the carcinogen N-hydroxy-N-2-acetylaminofluorene. 3. Oxidation with horseradish peroxidase to yield 2-nitrosofluorene and N-acetoxy-N-2-acetylaminofluorene. , 1971, Biochimica et biophysica acta.
[90] J. Miller,et al. Liver microsomal metabolism of aflatoxin B 1 to a reactive derivative toxic to Salmonella typhimurium TA 1530. , 1972, Cancer research.
[91] J. Miller,et al. N-Hydroxylation: A new metabolic reaction observed in the rat with the carcinogen 2-acetylaminofluorene. , 1960, The Journal of biological chemistry.
[92] J. Miller,et al. The N- and ringhydroxylation of 2-acetylaminofluorene during carcinogenesis in the rat. , 1960, Cancer research.
[93] J. Miller,et al. Studies on structures of polar dyes derived from the liver proteins of rats fed N-methyl-4-aminoazobenzene. 3. Tyrosine and homocysteine sulfoxide polar dyes. , 1969, Biochemistry.
[94] G. B. Brown,et al. Oncogenic purine N-oxide derivatives as substrates for sulfotransferase. , 1973, Cancer research.
[95] J. Miller,et al. Sulfotransferase Activation of N-Hydroxy-2-acetylaminofluorene in Rodent Livers Susceptible and Resistant to this Carcinogen∗ , 1968, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[96] J. Miller,et al. Guanyl O6-arylamination and O6-arylation of DNA by the carcinogen N-hydroxy-1-naphthylamine. , 1978, Cancer research.
[97] G. B. Brown,et al. Oncogenic Purine Derivatives: Evidence for a Possible Proximate Oncogen , 1970, Science.
[98] J. Miller,et al. The Carcinogenicity of Certain Azo Dyes Related to p-Dimethylaminoazobenzene , 1945 .
[99] C. Irving,et al. Reaction of the glucuronide of the carcinogen N-hydroxy-2-acetylaminofluorene with nucleic acids. , 1969, Biochimica et biophysica acta.
[100] J. Castro,et al. Studies on the irreversible binding of 14 C-CCl 4 to microsomal lipids in rats under varying experimental conditions. , 1972, Toxicology and applied pharmacology.
[101] J. Miller,et al. Electrophilic N-acetoxyaminoarenes derived from carcinogenic N-hydroxy-N-acetylaminoarenes by enzymatic deacetylation and transacetylation in liver. , 1972, Biochimica et biophysica acta.
[102] W. Lowrance,et al. Of Acceptable Risk: Science and the Determination of Safety , 1976 .
[103] G. Wogan,et al. In vitro metabolism of aflatoxin B2 by animal and human liver. , 1978, Cancer research.
[104] L. Fishbein,et al. Identification of tertiary aminomethylenedioxy-propiophenones as urinary metabolites of safrole in the rat and guinea pig , 1971 .
[105] P. Shubik,et al. A New, Quantitative, Approach to the Study of the Stages of Chemical Carcinogenesis in the Mouse's Skin , 1947, British Journal of Cancer.
[106] J. Miller,et al. 2,3-Dihydro-2,3-dihydroxy-aflatoxin B1: an acid hydrolysis product of an RNA-aflatoxin B1 adduct formed by hamster and rat liver microsomes in vitro. , 1973, Biochemical and biophysical research communications.
[107] A. Hewer,et al. Epoxides as microsomal metabolites of polycyclic hydrocarbons , 1971, FEBS letters.
[108] C. Heidelberger. Chemical oncogenesis in culture. , 1973, Advances in cancer research.
[109] H. Butlin. THREE LECTURES on CANCER of the SCROTUM in CHIMNEY-SWEEPS and OTHERS , 1892, British medical journal.
[110] J. Miller,et al. The metabolism of the naturally occurring hepatocarcinogen safrole to 1'-hydroxysafrole and the electrophilic reactivity of 1'-acetoxysafrole. , 1973, Cancer research.
[111] E. Miller,et al. The N-Hydroxylation of 4-Acetylaminobiphenyl by the Rat and Dog and the Strong Carcinogenicity of N-Hydroxy-4-acetylaminobiphenyl in the Rat , 1961 .
[112] H. P. Rusch,et al. Some Additive Effects of Carcinogenic Hydrocarbons , 1942 .
[113] J. Kmet. The role of migrant population in studies of selected cancer sites: a review. , 1970, Journal of chronic diseases.
[114] J. Miller,et al. N2 atom of guanine and N6 atom of adenine residues as sites for covalent binding of metabolically activated 1'-hydroxysafrole to mouse liver DNA in vivo. , 1981, Cancer research.
[115] J. Miller,et al. N-substitution of carbon 8 in guanosine and deoxyguanosine by the carcinogen N-benzoyloxy-N-methyl-4-aminoazobenzene in vitro. , 1975, Cancer research.
[116] E. Hecker. Structure-activity relationships in diterpene esters irritant and cocarcinogenic to mouse skin , 1978 .
[117] B. Ames,et al. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[118] T. Slaga,et al. Marked differences in the tumor-initiating activity of optically pure (+)- and (-)-trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene on mouse skin. , 1977, Cancer research.
[119] J. Westra,et al. Identification of the persistently bound form of the carcinogen N-acetyl-2-aminofluorene to rat liver DNA in vivo. , 1976, Chemico-biological interactions.
[120] J. Miller,et al. Aflatoxin B1-2,3-oxide: evidence for its formation in rat liver in vivo and by human liver microsomes in vitro. , 1974, Biochemical and biophysical research communications.
[121] J. Poiley,et al. Morphological transformation of early passage Golden Syrian Hamster embryo cells derived from cryopreserved primary cultures as a reliable in vitro bioassay for identifying diverse carcinogens , 1977, International journal of cancer.
[122] A. Conney. Pharmacological implications of microsomal enzyme induction. , 1967, Pharmacological reviews.
[123] J. Miller,et al. N-Hydroxy-2-acetylaminofluorene: a metabolite of 2-acetylaminofluorene with increased carcinogenic activity in the rat. , 1961, Cancer research.
[124] E. Miller,et al. Nucleic Acid Guanine: Reaction with the Carcinogen N-Acetoxy-2-Acetylaminofluorene , 1966, Science.
[125] M. Horning,et al. The metabolism of safrole and 2',3'-epoxysafrole in the rat and guinea pig. , 1974, Drug metabolism and disposition: the biological fate of chemicals.
[126] J. Miller,et al. Studies on structures of polar dyes derived from the liver proteins of rats fed N-methyl-4-aminoazobenzene. II. Identity of synthetic 3-(homocystein-S-yl)-N-methyl-4-aminoazobenzene with the major polar dye P2b. , 1968, Biochemistry.
[127] E. Miller,et al. Reaction of esters of aromatic N-hydroxy amines and amides with methionine in vitro: A model for in vivo binding of amine carcinogens to protein , 1966 .
[128] J. Radomski. The primary aromatic amines: their biological properties and structure-activity relationships. , 1979, Annual review of pharmacology and toxicology.
[129] J. Miller,et al. Mutations and decreases in density of transforming DNA produced by derivatives of the carcinogens 2-acetyl-aminofluorene and N-methyl-4-aminoazobenzene. , 1968, Molecular pharmacology.
[130] E. Kriek. On the interaction of N-2-fluorenylhydroxylamine with nucleic acids in vitro. , 1965, Biochemical and biophysical research communications.
[131] J Bunyan,et al. Treatment of Burns and Wounds by the Envelope Method , 1941, British medical journal.
[132] J. Miller,et al. Reactivity in vivo of the Carcinogen N-Hydroxy-2-acetylaminofluorene: Increase by Sulfate Ion , 1970, Science.
[133] F. Beland,et al. In vitro reaction of the carcinogen, N-hydroxy-2-naphthylamine, with DNA at the C-8 and N2 atoms of guanine and at the N6 atom of adenine. , 1980, Carcinogenesis.
[134] J. Miller,et al. CARCINOGENESIS AND INHIBITION OF THE WALKER 256 TUMOR IN THE RAT BY TRANS-4-ACETYLAMINOSTILBENE, ITS N-HYDROXY METABOLITE, AND RELATED COMPOUNDS. , 1964, Cancer research.
[135] E. Miller,et al. The Presence and Significance of Bound Aminoazo Dyes in the Livers of Rats Fed p-Dimethylaminoazobenzene , 1947 .
[136] J. Miller,et al. THE COMPARATIVE CARCINOGENICITIES OF 2-ACETYLAMINOFLUORENE AND ITS N-HYDROXY METABOLITE IN MICE, HAMSTERS, AND GUINEA PIGS. , 1964, Cancer research.
[137] J. Miller,et al. The metabolism of methylated aminoazo dyes. IV. Dietary factors enhancing demethylation in vitro. , 1954, The Journal of biological chemistry.
[138] E C Miller,et al. Hepatocarcinogenicity of estragole (1-allyl-4-methoxybenzene) and 1'-hydroxyestragole in the mouse and mutagenicity of 1'-acetoxyestragole in bacteria. , 1976, Journal of the National Cancer Institute.
[139] C. Linsell,et al. Dietary aflatoxins and human liver cancer. A study in Swaziland , 1976, International journal of cancer.
[140] J. Miller,et al. Biochemical investigations on hepatic carcinogenesis. , 1955, Journal of the National Cancer Institute.
[141] R. C. Garner,et al. Aflatoxin B-oxide generated by chemical or enzymic oxidation of aflatoxin B1 causes guanine substitution in nucleic acids , 1977, Nature.
[142] J. Miller,et al. 2,3-Dihydro-2-(guan-7-yl)-3-hydroxy-aflatoxin B1, a major acid hydrolysis product of aflatoxin B1-DNA or -ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo. , 1977, Cancer research.
[143] A. Haddow,et al. Chemistry of carcinogenic compounds. , 1946, British medical bulletin.
[144] W. Lijinsky,et al. Interaction of aflatoxins B1 and G1 with tissues of the rat. , 1970, Cancer research.
[145] J. Miller,et al. The metabolism of methylated aminoazo dyes. V. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene. , 1956, Cancer research.
[146] C. King,et al. Comparative effects of strain, species, and sex on the acyltransferase- and sulfotransferase-catalyzed activations of N-hydroxy-N-2-fluorenylacetamide. , 1975, Cancer research.
[147] J. Miller,et al. Carcinogenic and mutagenic activities of safrole, 1'-hydroxysafrole, and some known or possible metabolites. , 1977, Cancer research.
[148] H. Rubin. Is somatic mutation the major mechanism of malignant transformation? , 1980, Journal of the National Cancer Institute.
[149] G. Miller,et al. Tumorigenicity of embryonal carcinoma as an assay to study control of malignancy by the murine blastocyst. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[150] K. Illmensee,et al. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[151] C. Irving,et al. Biliary excretion of the O-glucuronide of N-hydroxy-2-acetylamino-fluorene by the rat and rabbit. , 1967, Cancer research.
[152] Freddy Homburger,et al. The physiopathology of cancer , 1959 .
[153] J. Miller,et al. The metabolism of 4-dimethylaminoazobenzene by rat liver homogenates. , 1948, The Journal of biological chemistry.
[154] F. Beland,et al. Characterization of DNA adducts of the carcinogen N-methyl-4-aminoazobenzene in vitro and in vivo. , 1980, Chemico-biological interactions.
[155] G. Mulder,et al. Alteration of urinary levels of the carcinogen, N-hydroxy-2-naphthylamine, and its N-glucuronide in the rat by control of urinary pH, inhibition of metabolic sulfation, and changes in biliary excretion. , 1981, Chemico-biological interactions.
[156] J. Miller,et al. Studies on the protein-bound aminoazo dyes formed in vivo from 4-dimethylaminoazobenzene and its C-monomethyl derivatives. , 1949, Cancer research.
[157] A. Hewer,et al. Metabolic activation of benzo(a)pyrene proceeds by a diol-epoxide , 1974, Nature.
[158] M S Legator,et al. Chemical characterization of 465 known or suspected carcinogens and their correlation with mutagenic activity in the Salmonella typhimurium system. , 1979, Cancer research.
[159] J. M. Blunck,et al. Enhancement of azo dye carcinogenesis by dietary sodium sulphate. , 1975, European journal of cancer.
[160] J. W. Flesher,et al. Possible role of 6‐hydroxymethylbenzo[a]pyrene as a proximate carcinogen of benzo[a]pyrene and 6‐methylbenzo[a]pyrene , 1973, International journal of cancer.
[161] D. Redmond. Tobacco and cancer: the first clinical report, 1761. , 1970, The New England journal of medicine.